Brief: Sutro Biopharma Q2 Revenue USD 25.706 Million Vs. IBES Estimate USD 21 Million
13/08/2024 21:30
Aug 13 (Reuters) - Sutro Biopharma Q2 operating income USD -48.685 million vs. IBES estimate USD -50.7 million. * Q2 basic EPS USD -0.59 * Q2 net income USD -48.018 million vs. IBES estimate USD -49.6 million * Q2 operating expenses USD 74.391 million
Recent news on Sutro Biopharma
See all newsBrief: Sutro Biopharma Announces First Patient Dosed In Phase 1 Trial Of STRO-006
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Sutro Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary
Sutro Biopharma tumbles after missing estimates